1. Willcox MDP, Argüeso P, Georgiev GA, Holopainen JM, Laurie GW, Millar TJ, et al. TFOS DEWS II Tear Film Report. Ocul Surf. 2017 Jul;15(3):366-403.
2. Gomes JAP, Azar DT, Baudouin C, Efron N, Hirayama M, Horwath-Winter J, et al. TFOS DEWS II iatrogenic report. Ocul Surf. 2017; Jul;15(3):511-538.
3. Baudouin C, Hamard P, Liang H, Creuzot-Garcher C, Bensoussan L, Brignole F. Conjunctival epithelial cell expression of interleukins and inflammatory markers in glaucoma patients treated over the long term. Ophthalmology. 2004 Dec;111(12):2186-92.
4. Baudouin C, Liang H, Hamard P, Riancho L, Creuzot-Garcher C, Warnet JM, et al. The ocular surface of glaucoma patients treated over the long term expresses inflammatory markers related to both T-helper 1 and T-helper 2 pathways. Ophthalmology. 2008 Jan;115(1):109-15.
5. Zhang X, Vadoothker S, Munir WM, Saeedi O. Ocular Surface Disease and Glaucoma Medications: A Clinical Approach. Eye Contact Lens. 2019 Jan;45(1):11-18.
6. Johnson ME, Murphy PJ. Changes in the tear film and ocular surface from dry eye syndrome. Prog Retin Eye Res . 2004;23(4):449-474.
7. Doughty MJ. pH dependent spectral properties of sodium fluorescein ophthalmic solutions revisited. Ophthalmic Physiol Opt. 2010;30(2):167-174.
8. Willcox MDP, Argüeso P, Georgiev GA, Holopainen JM, Laurie GW, Millar TJ, et al. TFOS DEWS II Tear Film Report. Ocul Surf. 2017 Jul;15(3):366-403.
9. Lan W, Lin L, Yang X, Yu M. Automatic Noninvasive Tear Breakup Time (TBUT) and Conventional Fluorescent TBUT. Optom Vis Sci. 2014;91(12):1412-1418.
10. Wolffsohn JS, Arita R, Chalmers R, Djalilian A, Dogru M, Dumbleton K, et al. TFOS DEWS II Diagnostic Methodology report. Ocul Surf. 2017 Jul;15(3):539-574.
11. Liu H, Begley CG, Chalmers R, Wilson G, Srinivas SP, Wilkinson JA. Temporal progression and spatial repeatability of tear breakup. Optom Vis Sci. 2006 Oct;83(10):723-30.
12. Arita R, Itoh K, Inoue K, Amano S. Noncontact infrared meibography to document age-related changes of the meibomian glands in a normal population. Ophthalmology. 2008 May;115(5):911-5.
13. Bron A, Evans VE, Smith JA. (2003). Grading of corneal and conjunctival staining in the context of other dry eye tests. Cornea 22(7): 640-50.
14. Ramoth T, Hovakimyan M, Guthoff RF, Stachs O. [Characterisation of tear film dynamics after application of trehalose for treatment of dry eye]. Klin Monbl Augenheilkd. 2013 Dec;230(12):1220-4.
15. Abdelfattah NS, Dastiridou A, Sadda SR, Lee OL. Noninvasive Imaging of Tear Film Dynamics in Eyes With Ocular Surface Disease. Cornea. 2015 Oct;34 Suppl 10:S48-52.
16. Zhu K, Xie W, Ying J, Yao Y. [Evaluation of tear film and meibomian gland function in dry eye patients using Keratograph 5M]. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2016 May 25;45(4):422-428. Chinese. PubMed PMID: 27868417.
17. Tian L, Qu JH, Zhang XY, Sun XG. Repeatability and Reproducibility of Noninvasive Keratograph 5M Measurements in Patients with Dry Eye Disease. J Ophthalmol. 2016;2016:8013621.
18. Wang X, Lu X, Yang J, Wei R, Yang L, Zhao S, Wang X. Evaluation of Dry Eye and Meibomian Gland Dysfunction in Teenagers with Myopia through Noninvasive Keratograph. J Ophthalmol. 2016;2016:6761206.
19. Qi Y, Zhang C, Zhao S, Huang Y, Yang R. A novel noninvasive ocular surface analyzer for the assessment of dry eye with Meibomian gland dysfunction. Exp Ther Med. 2017 Jun;13(6):2983-2988.
20. Koprowski R, Wilczyński S, Olczyk P, Nowińska A, Węglarz B, Wylęgała E. A quantitative method for assessing the quality of meibomian glands. Comput Biol Med. 2016 Aug 1;75:130-8.
21. Jung JW, Kim JY, Chin HS, Suh YJ, Kim TI, Seo KY. Assessment of meibomian glands and tear film in post-refractive surgery patients. Clin Exp Ophthalmol. 2017 Dec;45(9):857-866.
22. Yu T, Shi WY, Song AP, Gao Y, Dang GF, Ding G. Changes of meibomian glands in patients with type 2 diabetes mellitus. Int J Ophthalmol. 2016 Dec 18;9(12):1740-1744. doi: 10.18240/ijo.2016.12.06. eCollection 2016. PubMed PMID: 28003972; PubMed Central PMCID: PMC5154985.
23. Pérez-Bartolomé F, Martínez-de-la-Casa JM, Arriola-Villalobos P, Fernández-Pérez C, Polo V, García-Feijoó J. Ocular Surface Disease in Patients under Topical Treatment for Glaucoma. Eur J Ophthalmol. 2017 Nov 8;27(6):694-704.
24. Pérez Bartolomé F, Martínez de la Casa JM, Arriola Villalobos P, Fernández Pérez C, Polo V, Sánchez Jean R, et al. Ocular Redness Measured with the Keratograph 5M in Patients Using Anti-Glaucoma Eye Drops. Semin Ophthalmol. 2018;33(5):643-650.
25. Ji YW, Lee J, Lee H, Seo KY, Kim EK, Kim TI. Automated Measurement of Tear Film Dynamics and Lipid Layer Thickness for Assessment of Non-Sjögren Dry Eye Syndrome With Meibomian Gland Dysfunction. Cornea. 2017 Feb;36(2):176-182.
26. Li W, Lin MC. Pain Sensitivity Associated with the Length of the Maximum Interblink Period. Investig Opthalmology Vis Sci. 2018;59(1):245.
27. Yokoi N, Georgiev GA, Kato H, Komuro A, Sonomura Y, Sotozono C, et al. Classification of Fluorescein Breakup Patterns: A Novel Method of Differential Diagnosis for Dry Eye. Am J Ophthalmol. 2017 Aug;180:72-85.
28. Yokoi N, Georgiev GA. Tear Film-Oriented Diagnosis and Tear Film-Oriented Therapy for Dry Eye Based on Tear Film Dynamics. Invest Ophthalmol Vis Sci. 2018 Nov 1;59(14):DES13-DES22.